PEAQX Catalog No.:M8604-2 The effect starts 5 minutes

The effect starts 5 minutes after the injection

Tizoxanide is a potent inhibitor of hepatitis B virus and hepatitis C virus replication

VX 765 (50-200 mg/kg) significantly reduces serum IL-1β levels by as much as 60%

Genz-123346 and a few other GCS inhibitors are substrates for multi-drug resistance efflux pumps such as P-gp (ABCB1

InChi: InChI=1S/C18H16OS

PEAQX Catalog No.:M8604-2 The effect starts 5 minutesPEAQX, also known as NVP AAM077; is a competitive antagonist at the NMDA receptor. Although originally described as 100 fold selective for GluN1 GluN2A receptors vs. GluN1 GluN2B receptors, more detailed studies of the Ki of PEAQX revealed it only shows a 5 fold difference in affinity for GluN1 GluN2A vs. GluN1 GluN2B receptors. It is also a potent anticonvulsant in animal tests. Product information CAS Number: 459836 30 7 Molecular Weight: 454. 21